首页> 外文OA文献 >Bacterial Ghosts as an Oral Vaccine: a Single Dose of Escherichia coli O157:H7 Bacterial Ghosts Protects Mice against Lethal Challenge
【2h】

Bacterial Ghosts as an Oral Vaccine: a Single Dose of Escherichia coli O157:H7 Bacterial Ghosts Protects Mice against Lethal Challenge

机译:作为口服疫苗的细菌性幽灵:单剂量的大肠杆菌O157:H7细菌性幽灵可保护小鼠免受致命性攻击

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Enterohemorrhagic Escherichia coli (EHEC) is a bacterial pathogen that is associated with several life-threatening diseases for humans. The combination of protein E-mediated cell lysis to produce EHEC ghosts and staphylococcal nuclease A to degrade DNA was used for the development of an oral EHEC vaccine. The lack of genetic material in the oral EHEC bacterial-ghost vaccine abolished any hazard of horizontal gene transfer of resistance genes or pathogenic islands to resident gut flora. Intragastric immunization of mice with EHEC ghosts without the addition of any adjuvant induced cellular and humoral immunity. Immunized mice challenged at day 55 showed 86% protection against lethal challenge with a heterologous EHEC strain after single-dose oral immunization and 93.3% protection after one booster at day 28, whereas the controls showed 26.7% and 30% survival, respectively. These results indicate that it is possible to develop an efficacious single-dose oral EHEC bacterial-ghost vaccine.
机译:肠出血性大肠杆菌(EHEC)是一种细菌病原体,与多种威胁人类生命的疾病有关。蛋白质E介导的细胞裂解产生EHEC鬼影和葡萄球菌核酸酶A降解DNA的组合被用于开发口服EHEC疫苗。口服EHEC细菌幽灵疫苗缺乏遗传物质,消除了耐药基因或致病岛向居民肠道菌群的水平基因转移的任何危害。在不添加任何佐剂诱导的细胞和体液免疫的情况下,用EHEC幽灵对小鼠进行胃内免疫。在第55天攻击的免疫小鼠在单剂量口服免疫后对异源EHEC株的致死性攻击表现出86%的保护作用,在第28天一次加强免疫后表现出93.3%的保护作用,而对照组则分别显示出26.7%和30%的存活率。这些结果表明有可能开发有效的单剂量口服EHEC细菌幽灵疫苗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号